Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort
Authors:
Open Access
- 17 December 2012
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 24 (5) , 1262-1266
Abstract
Chemoradiation followed by surgery is the preferred treatment of localized gastroesophageal cancer (GEC). Surgery causes considerable life-altering consequences and achievement of clinical complete response (clinCR; defined as postchemoradiation [but presurgery] endoscopic biopsy negative for cancer and positron emission tomographic (PET) scan showing physiologic uptake) is an enticement to avoid/delay surgery. We examined the association between clinCR and pathologic complete response (pathCR). Two hundred eighty-four patients with GEC underwent chemoradiation and esophagectomy. The chi-square test, Fisher exact test, t-test, Kaplan–Meier method, and log-rank test were used. Of 284 patients, 218 (77%) achieved clinCR. However, only 67 (31%) of the 218 achieved pathCR. The sensitivity of clinCR for pathCR was 97.1% (67/69), but the specificity was low (29.8%; 64/215). Of the 66 patients who had less than a clinCR, only 2 (3%) had a pathCR. Thus, the rate of pathCR was significantly different in patients with clinCR than in those with less than a clinCR (P < 0.001). clinCR is not highly associated with pathCR; the specificity of clinCR for pathCR is too low to be used for clinical decision making on delaying/avoiding surgery. Surgery-eligible GEC patients should be encouraged to undergo surgery following chemoradiation despite achieving a clinCR.Keywords
Funding Information
- Dallas, Park, Smith, and Cantu family funds
- the Kevin Fund
- the Sultan Fund
- the River Creek Foundation
- the Aaron and Martha Schecter Private Foundation
- University of Texas MD Anderson Cancer Center
- National Institutes of Health through MD Anderson Cancer Center (CA016672)
This publication has 27 references indexed in Scilit:
- Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapyCancer, 2011
- Improved Outcomes in the Management of Esophageal Cancer with the Addition of Surgical Resection to Chemoradiation TherapyAnnals of Surgical Oncology, 2010
- Phase 2 trial of preoperative irinotecan plus cisplatin and conformal radiotherapy, followed by surgery for esophageal cancerCancer, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Environmental Causes of Esophageal CancerGastroenterology Clinics of North America, 2009
- Worldwide esophageal cancer collaborationDiseases of the Esophagus, 2009
- Incidence of Adenocarcinoma of the Esophagus Among White Americans by Sex, Stage, and AgeJNCI: Journal of the National Cancer Institute, 2008
- Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781Journal of Clinical Oncology, 2008
- The Role of Overdiagnosis and Reclassification in the Marked Increase of Esophageal Adenocarcinoma IncidenceJNCI: Journal of the National Cancer Institute, 2005
- A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinomaAnnals of Oncology, 2004